Marrone Bio Innovations Probability of Future Stock Price Finishing Under 0.8
| MBIIDelisted Stock | USD 0.80 0.00 0.00% |
Marrone |
Marrone Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Marrone Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Marrone Bio Innovations can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Marrone Bio is not yet fully synchronised with the market data | |
| Marrone Bio has some characteristics of a very speculative penny stock | |
| Marrone Bio has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 35.46 M in liabilities with Debt to Equity (D/E) ratio of 1.55, which is about average as compared to similar companies. Marrone Bio Innovations has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Marrone Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Marrone Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Marrone Bio Innovations sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Marrone to invest in growth at high rates of return. When we think about Marrone Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 44.37 M. Net Loss for the year was (20.89 M) with profit before overhead, payroll, taxes, and interest of 27.25 M. | |
| Marrone Bio Innovations currently holds about 9.36 M in cash with (13.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 68.0% of Marrone Bio shares are owned by institutional investors |
Marrone Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Marrone Stock often depends not only on the future outlook of the current and potential Marrone Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Marrone Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 0.99% | |
| Short Percent Of Float | 2.18% | |
| Float Shares | 88.51M | |
| Shares Short Prior Month | 3.12M | |
| Average Daily Volume In Three Month | 675.74k | |
| Date Short Interest | 30th of June 2022 |
Marrone Bio Technical Analysis
Marrone Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Marrone Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Marrone Bio Innovations. In general, you should focus on analyzing Marrone Stock price patterns and their correlations with different microeconomic environments and drivers.
Marrone Bio Predictive Forecast Models
Marrone Bio's time-series forecasting models is one of many Marrone Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Marrone Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Marrone Bio Innovations
Checking the ongoing alerts about Marrone Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Marrone Bio Innovations help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Marrone Bio is not yet fully synchronised with the market data | |
| Marrone Bio has some characteristics of a very speculative penny stock | |
| Marrone Bio has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 35.46 M in liabilities with Debt to Equity (D/E) ratio of 1.55, which is about average as compared to similar companies. Marrone Bio Innovations has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Marrone Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Marrone Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Marrone Bio Innovations sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Marrone to invest in growth at high rates of return. When we think about Marrone Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 44.37 M. Net Loss for the year was (20.89 M) with profit before overhead, payroll, taxes, and interest of 27.25 M. | |
| Marrone Bio Innovations currently holds about 9.36 M in cash with (13.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 68.0% of Marrone Bio shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Marrone Stock
If you are still planning to invest in Marrone Bio Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Marrone Bio's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |